Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oragenics Inc. Common Stock (NY: OGEN )

0.2980 +0.0040 (+1.36%)
Official Closing Price Updated: 8:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oragenics Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
Executives Buy Around $5.5M Of 3 Penny Stocks
US crude oil futures traded higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... 
Via Benzinga
4 Penny Stocks Insiders Are Buying
US crude oil futures traded sharply lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation
From Oragenics, Inc.
Via Business Wire
Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1
From Oragenics, Inc.
Via Business Wire
Oragenics Partners With KBI Biopharma To Produce Material For Its Intranasal COVID-19 Vaccine Candidate
Oragenics Inc (NYSE: OGEN) has entered into an agreement with KBI Biopharma Inc for the process transfer, process optimization, and cGMP manufacturing of... 
Via Benzinga
Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
From Oragenics, Inc.
Via Business Wire
5 Stocks Insiders Are Buying Right Now
Several stocks that insiders are buying are worth watching as we enter the new year. This week, that list includes F, CRCT, CHWY and OGEN. 
Via InvestorPlace
45 Biggest Movers From Yesterday
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... 
Via Benzinga
Nvidia Omniverse: 14 Things for NVDA Stock Investors to Know About the Metaverse Project
Nvidia (NVDA) is bringing its metaverse project, titled Omniverse, out of beta and letting creators take advantage of the service. 
Via InvestorPlace
Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge
Midway through trading Tuesday, the Dow traded up 0.66% to 36,827.65 while the NASDAQ fell 1.63% to 15,574.50. The S&P also fell, dropping 0.08% to 4,792.93. The U.S. has the... 
Via Benzinga
OGEN Stock Alert: The Insider Buying Giving Oragenics Shares Some Oomph Today
Oragenics (OGEN) stock is rising higher on Tuesday following news of massive insider buying at the development-stage company. 
Via InvestorPlace
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women... 
Via Benzinga
23 Stocks Moving in Tuesday's Pre-Market Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc... 
Via Benzinga
Oragenics Extends Collaboration with NRC Canada For Omicron-Specific Vaccine
Oragenics Inc (NYSE: OGEN) has extended a licensing and collaboration agreement with the National Research Council of Canada (NRC) to enable Oragenics to pursue an... 
Via Benzinga
Oragenics Extends Collaboration with the National Research Council of Canada to Develop Vaccine against the Omicron Variant
From Oragenics, Inc.
Via Business Wire
Oragenics to Participate in Virtual Fireside Chat Hosted by Alliance Global Partners
From Oragenics, Inc.
Via Business Wire
Oragenics Co-Authors a Publication Describing the Dual Mechanism of Action of Lantibiotics
From Oragenics, Inc.
Via Business Wire
Oragenics COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action
Oragenics Inc (NYSE: OGEN) announced the results from its hamster challenge study to evaluate the COVID-19 vaccine candidate. The study is assessing the... 
Via Benzinga
Exposures COVID-19
Oragenics Announces Positive COVID-19 Challenge Study Results Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
From Oragenics, Inc.
Via Business Wire
20 Stocks Moving In Tuesday's Pre-Market Session
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) rose 117.3% to $4.78 in pre-market trading after the company announced the FDA approved expanded labeling for Caldolor to... 
Via Benzinga
Exposures Product Safety
Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
From Oragenics, Inc.
Via Business Wire
25 Stocks Moving in Tuesday's Pre-Market Session
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 95.1% to $23.22 in pre-market trading after jumping around 24% on Monday. Diginex Limited (NASDAQ: EQOS) rose 74.5% to $7.... 
Via Benzinga
Oragenics Awarded a $250,000 Grant from the National Institute of General Medical Sciences (NIGMS) for the Continued Research and Development of Lantibiotics.
From Oragenics, Inc.
Via Business Wire
Oragenics Launches Animal Study For COVID-19 Vaccine Candidate
Oragenics Inc (NYSE: OGEN) has initiated a hamster challenge study to evaluate the immunogenicity and viral load reduction impact of its COVID-19 vaccine candidate... 
Via Benzinga
Exposures COVID-19
Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
From Oragenics, Inc.
Via Business Wire
48 Biggest Movers From Yesterday
Gainers RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding,... 
Via Benzinga
Exposures Product Safety
35 Stocks Moving In Monday's Mid-Day Session
Gainers Globalstar, Inc. (NYSE: GSAT) shares climbed 43.6% to $2.0535. GSAT shares traded higher following a note sent out by popular Apple Inc. (NASDAQ: AAPL) analyst Ming... 
Via Benzinga
Oragenics's New Preclinical Data Supports Its Approach For COVID-19 Vaccine Development
Oragenics Inc's (NYSE: OGEN) stabilized pre-fusion spike protein trimer generates neutralizing antibodies in mice after immunization against SARS-CoV-2 when... 
Via Benzinga
Exposures COVID-19
Oragenics’ SARS-CoV-2 Spike Protein Produces Neutralizing Antibodies in Mice with Intramuscular and Intranasal Adjuvants
From Oragenics, Inc.
Via Business Wire
Oragenics Announces Postponement of Annual Meeting of Shareholders
From Oragenics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.